Expand CRBP Menu
CRBP MENU

CRBP Latest Press Releases

-- May 26, 2026 --

Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers Globe Newswire 7:00 AM

-- May 21, 2026 --

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call Globe Newswire 8:00 AM

-- May 14, 2026 --

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors Globe Newswire 8:00 AM

-- May 13, 2026 --

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- May 12, 2026 --

Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update Globe Newswire 8:00 AM

-- May 5, 2026 --

Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026 Globe Newswire 8:00 AM

-- April 22, 2026 --

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701 Globe Newswire 8:00 AM

-- April 14, 2026 --

Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity Globe Newswire 8:00 AM

-- April 7, 2026 --

Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer Globe Newswire 8:00 AM

-- March 18, 2026 --

Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit Globe Newswire 8:00 AM

-- March 9, 2026 --

Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update Globe Newswire 7:30 AM

-- February 12, 2026 --

Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes